Literature DB >> 11745072

Post-traumatic fibro-osseous lesion of the ribs and scapula (sclerosing xanthofibroma).

M Blanco1, B Cabello-Inchausti, M Cura, L Fernandes.   

Abstract

Fibrous lesions of bone may be difficult to classify. Their etiology is controversial, most being considered to be developmental lesions rather than true neoplasms. We describe a patient with post-traumatic fibro-osseous lesion of the ribs, also known as sclerosing xanthofibroma; a lesion believed to be a reactive response to intramedullary hemorrhage following chest wall trauma. Clinically, the lesions in our patient were thought to be metastatic disease because of their multifocal appearance. An extensive clinical and laboratory metastatic evaluation with surgical resection of one of the lesions using intraoperative gamma probe was undertaken. In addition to the multiple rib involvement, our case also showed a lesion in the scapula. The pathologic and radiologic features of this entity are reviewed along with the summary of the differential diagnosis. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745072     DOI: 10.1053/adpa.2001.29342

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  3 in total

1.  Post-traumatic fibro-osseous lesion of the ribs: a relatively under-recognised entity.

Authors:  S Aubert; O Kerdraon; M Conti; D Buob; S Petit; X Leroy
Journal:  J Clin Pathol       Date:  2006-02-07       Impact factor: 3.411

2.  Posttraumatic reactive fibrous bone neoformation of the anterior skull base mimicking osteosarcoma.

Authors:  Jens Pfeiffer; Gian Kayser; Carsten C Boedeker; Gerd J Ridder
Journal:  Skull Base       Date:  2008-09

3.  Sclerosing xanthofibroma of the rib that mimics a very aggressive malignant tumor of the thoracic wall.

Authors:  F Caushi; D Xhemalaj; I Bani; I Skenduli; B Gega; H Hafizi; A Mezini
Journal:  Case Rep Pulmonol       Date:  2014-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.